Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients

BACKGROUND: Acute myeloid leukemia (AML) is a group of highly heterogenous and aggressive blood cancer. Despite recent progress in its diagnosis and treatment, patient outcome is variable and drug resistance results in increased mortality. The siglec family plays an important role in tumorigenesis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Huiping, Gao, Liang, Zhang, Weili, Jiang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295398/
https://www.ncbi.nlm.nih.gov/pubmed/35854240
http://dx.doi.org/10.1186/s12859-022-04841-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295398/
https://www.ncbi.nlm.nih.gov/pubmed/35854240
http://dx.doi.org/10.1186/s12859-022-04841-5

Ejemplares similares